Skip to main content
. 2016 Oct 27;11(10):e0163542. doi: 10.1371/journal.pone.0163542

Fig 2. Gas6 and soluble Axl (sAxl) levels.

Fig 2

(A) Gas6 plasma levels at admission in septic patients with shock (median 180.5, IQR 130) and without shock (median 173, IQR 104) (P > 0.05, Wilcoxon rank-sum (Mann-Whitney) test), (B) sAxl plasma levels at admission in septic patients with shock (median 35, IQR 20.5) and septic patients without shock (median 31, IQR 13) (P > 0.05, Wilcoxon rank-sum (Mann-Whitney) test), (C) Gas6 plasma levels at admission in survivors (median 167%, IQR 106) and non-survivors (median 238%, IQR 217) (P = 0.003, Wilcoxon rank-sum (Mann-Whitney) test), (D) sAxl plasma levels at admission in survivors (median 31, IQR 14.5) and non-survivors (median 34.5, IQR 29) (P > 0.05, Wilcoxon rank-sum (Mann-Whitney) test).